Draft:Eidogen-Sertanty

• Comment: See address WP:COI and do not remove previous declines. See also WP:CIRCULAR. Greenman (talk) 16:50, 7 April 2024 (UTC)

• Comment: It's not clear how this meets WP:NCORP criteria from the citations. ~Liance^talk 22:00, 13 December 2023 (UTC)

• Comment: Well done on creating the draft, and it may potentially meet the relevant requirements (including WP:GNG, WP:NCORP) but presently it is not clear that it does. As you may know, Wikipedia's basic requirement for entry is that the subject is notable. Essentially subjects are presumed notable if they have received significant coverage in multiple published secondary sources that are reliable, intellectually independent of each other, and independent of the subject. To properly create such a draft page, please see the articles ‘Your First Article’, ‘Referencing for Beginners’ and ‘Easier Referencing for Beginners’. Also, if you have any connection to the subject, including being paid, you have a conflict of interest that you must declare on your Talk page (to see instructions on how to do this please click the link). Please familiarise yourself with these pages before amending the draft. If you feel you can meet these requirements, then please make the necessary amendments before resubmitting the page. It would help our volunteer reviewers by identifying, on the draft's talk page, the WP:THREE best sources that establish notability of the subject. You may also wish to leave a note for me on my talk page and I would be happy to reassess. Cabrils (talk) 02:57, 16 November 2023 (UTC)

Eidogen-Sertanty, Inc.

Industry	Computer software Cheminformatics
Founded	2003; 21 years ago (2003)
Founder	Steven Muskal (CEO)
Headquarters	San Diego, California , United States
Website	www.eidogen-sertanty.com

Eidogen-Sertanty is an American software company founded in 2003. Eidogen-Sertanty provides software^[1] and content^[2] and engages in collaborative services^[3] which accelerate the drug discovery process.